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This review summarizes the current status and recent advances in our understanding of
the role that the cytolethal distending toxin (Cdt) plays as a virulence factor in promoting
disease by toxin-producing pathogens. A major focus of this review is on the relationship
between structure and function of the individual subunits that comprise the AB2 Cdt
holotoxin. In particular, we concentrate on the molecular mechanisms that characterize
this toxin and which account for the ability of Cdt to intoxicate multiple cell types by
utilizing a ubiquitous binding partner on the cell membrane. Furthermore, we propose a
paradigm shift for the molecular mode of action by which the active Cdt subunit, CdtB,
is able to block a key signaling cascade and thereby lead to outcomes based upon
programming and the role of the phosphatidylinositol 3-kinase (PI-3K) in a variety of cells.
Based upon the collective Cdt literature, we now propose that Cdt is a unique and potent
virulence factor capable of acting as a tri-perditious toxin that impairs host defenses
by: (1) disrupting epithelial barriers; (2) suppressing acquired immunity; (3) promoting
pro-inflammatory responses. Thus, Cdt plays a key role in facilitating the early stages of
infection and the later stages of disease progression by contributing to persistence and
impairing host elimination.
Keywords: toxin, virulence, PI-3 kinase, inflammation, epithelial cells, lymphocytes, macrophages
INTRODUCTION
The cytolethal distending toxin (Cdt) was first described by Johnson and Lior (1988a,b) as a
heat-labile toxin present in culture filtrates obtained from clinical isolates of Campylobacter spp.
(including C. jejuni, C. coli, C. fetus, C. lari), Escherichia coli and Shigella dysenteriae. Specifically,
Cdt-containing filtrates were reported to adversely affect CHO cells, Vero cells, HeLa cells, and
Hep-2 cells by inducing a progressive distention over 96 h and eventually leading to loss of cell
vitality between 96 and 120 h. Interestingly, the murine adrenal tumor cell line, Y-1, was not
susceptible to Cdt toxicity. This was a key observation as Y-1 cells were commonly used to assess the
classic heat-labile toxin (LT), thereby allowing these investigators to proclaim the discovery of a new
and unique toxin. To date there has been much progress on our understanding of Cdts since the
report of these seminal observations. For instance, Cdts are now known to represent a conserved
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and highly distributed family of putative virulence factors
produced by a diverse group of more than 30 γ- and ε-
Proteobacteria which are responsible for chronic infection and
inflammatory disease typically affecting mucocutaneous tissue
(summarized in Table 1). Human pathogens that produce Cdt
include: an oral pathogen, a genital pathogen responsible
for sexually transmitted chancroid, gastric pathogens, and
carcinogenic pathogens; these include both human and animal
pathogens (Whitehouse et al., 1998; Shenker et al., 1999; Lara-
Tejero and Galán, 2001; Haghjoo and Galán, 2004; Thelastam
and Frisan, 2004; Young et al., 2004; Ge et al., 2005, 2007; Gargi
et al., 2012; DiRienzo, 2014). Moreover, regardless of microbial
source, all Cdts cause similar effects on a range of proliferating
experimental target cells: cell cycle arrest and eventual cell death
mediated by activation of the apoptotic cascade (Jinadasa et al.,
2011). More recent observations suggest that Cdt is capable of
inducing functional alterations in the absence of cell death in
non-proliferating populations (Shenker et al., 2010, 2014).
Cdts are encoded by three genes, designated cdtA, cdtB, and
cdtC, which are arranged as an operon which encodes three
polypeptides which have been designated CdtA, CdtB, and CdtC
with apparent molecular masses of 23–30, 28–32, and 19–20 kDa,
respectively; these Cdt subunits form a heterotrimeric holotoxin
(Pickett and Whitehouse, 1999; Shenker et al., 1999, 2000, 2001;
De Rycke and Oswald, 2001; Thelastam and Frisan, 2004). Cdt
toxin subunits are encoded by three marginally overlapping
chromosomal genes cdtA, cdtB, and cdtC (Pickett et al., 1994;
Scott and Kaper, 1994; Okuda et al., 1995). However, Escherichia
coli cdtB-III gene cluster is located on a transferable plasmid pVir
(Pérès et al., 1997). In contrast to all other bacteria expressing
Cdt, Salmonella enterica serotype Typhi (S. Typhi) lack genes
encoding CdtA and CdtC (Haghjoo and Galán, 2004; Skyberg
et al., 2006; Suez et al., 2013; Mezal et al., 2014; Figueiredo et al.,
2015).
Although all Cdts exhibit similar activity, their amino acid
sequences diverged among different bacterial species (Nesic
et al., 2004). The CdtB sequences are more conserved among
the Cdt-producing bacteria while the CdtA and CdtC subunits
display a higher degree of variability (Cortes-Bratti et al.,
2001; Lara-Tejero and Galán, 2001; Smith and Bayles, 2006).
Bacteria from Escherichia genus are unique in the fact that
five types of Cdts, termed EcolCdtB-I, EcolCdtB-II, EcolCdtB-
III, EcolCdtB-IV, and EcolCdtB-V have been characterized so
far based on CdtB subunit divergence. C. jejuni Cdt displays a
relatively high amino acid sequence similarity to E. coli toxins
and interacts with host cells in a similar way (Eshraghi et al.,
2010). The Cdts from Haemophilus ducreyi and Aggregatibacter
actinomycetemcomitans share only limited amino acid sequence
homology with E. coli Cdt and were shown to have different
requirements for intoxication and intracellular trafficking in
host cells (Eshraghi et al., 2014). The cdtB genes from seven
Campylobacter species are conserved and can be amplified using
common primers (Kamei et al., 2014).
In this review, we summarize our current understanding of the
functional role of the subunits that comprise the Cdt holotoxin
and, in particular, discuss the molecular mechanisms that
underlay Cdt association with host cells and which contribute
to the key events leading to toxicity. As Cdt has profound
effects on multiple types of host cells, we discuss the evidence
supporting a role for Cdt as a virulence factor. Specifically,
we propose that Cdt is a unique and potent virulence factor
capable of acting as a tri-perditious toxin that impairs host
defenses by: (1) disrupting epithelial barriers; (2) suppressing
acquired immunity; (3) promoting pro-inflammatory responses
(summarized in Figure 1).
Cdt SUBUNIT STRUCTURE AND
FUNCTION
Cdt Subunits Responsible for Cell
Association
It is generally accepted that all three Cdt subunits, CdtA,
CdtB, and CdtC, are required to achieve maximal toxic activity,
regardless of the target cell. Thus, the holotoxin is believed to
function as an AB2 toxin where the cell binding unit (B) is
responsible for toxin binding to the cell surface and delivery
of the active subunit (A) to intracellular compartments. In
the context of Cdt, binding activity is considered to be the
result of cooperative activities of both the CdtA and CdtC
subunits (reviewed in Gargi et al., 2012). Moreover, it has
been proposed that these subunits share structural homology
with lectin-like proteins and further, that fucose moieties might
be involved in toxin association with the cell surface (Nesic
et al., 2004; McSweeney and Dreyfus, 2005). In other studies,
glycosphingolipids have been implicated as possible binding
sites as inhibitors of glycosphingolipid synthesis reduce Cdt
intoxication (Mise et al., 2005). It should be pointed out that in a
more recent study in which Cdts from different microbial species
were studied simultaneously, toxin-host interactions were shown
not to depend upon fucosylated structures as well as N- and
O-glycans (Eshraghi et al., 2010). These authors did, however,
observe that several Cdts, including toxin prepared from
A. actinomycetemcomitans, C. jejuni, and H. ducreyi, utilized
membrane cholesterol; these results corroborated the findings of
several other investigators (Guerra et al., 2005; Boesze-Battaglia
et al., 2009; Zhou et al., 2012; Lai et al., 2013, 2015).
The ability of Cdt to specifically bind to cholesterol has
been demonstrated utilizing both model membranes as well
as live cells including both lymphocytes and macrophages
(Boesze-Battaglia et al., 2006, 2009; Shenker et al., 2014).
Moreover, cholesterol specific binding was shown to depend
upon an amino acid sequence, the cholesterol recognition amino
acid consensus sequence (CRAC), encoded within the CdtC
subunit (Boesze-Battaglia et al., 2009). The CRAC site has been
defined as: -L/V-(X1−5)-Y-(X1−5)-R/K- where X1−5 represents
1–5 residues of any amino acid. Furthermore, Boesze-Battaglia
(Boesze-Battaglia et al., 2009) have demonstrated not only the
presence of this site within the A. actinomycetemcomitans CdtC
subunit, -68LIDYKGK74-, but also that mutation of key CRAC
residues results in reduced toxin binding, CdtB internalization,
and toxicity (Boesze-Battaglia et al., 2009). More recently, a
similar site has been identified for the CdtB subunit of the
A. actinomycetemcomitans toxin (Boesze-Battaglia et al., 2015)
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FIGURE 1 | Overview of Cdt’s role as a virulence factor. Most Cdts are heterotrimeric AB2 toxins that are capable of affecting multiple cell types due to the ability
of the binding (B) subunits to bind to cells via a common membrane moiety, cholesterol. Furthermore, the active (A) subunit, CdtB, functions as a PIP3 phosphatase
and is therefore capable of inducing a blockade of a universally employed signaling cascade, PI-3K. We now propose that in its capacity as a virulence factor, Cdt
functions as a tri-perditious toxin that is capable of impairing host defense in three ways: (1) induce cell cycle arrest and apoptosis in epithelial cells thereby altering
epithelial barriers and facilitating infection by Cdt-producing pathogens; (2) induce cell cycle arrest and apoptosis in lymphocytes thereby impairing acquired immunity
and promoting persistent infection; and (3) altering macrophage function leading to a pro-inflammatory response as a result of increased cytokine synthesis and
inflammasome activation. Please note that we have not excluded the possibility that some Cdts and/or some cells may under some conditions be intoxicated as a
result of CdtB associated DNase activity.
and is the focus of other papers in this section. It is also
noteworthy that the presence of CRAC sites and utilization of
cholesterol specific binding has been demonstrated for several
proteins including the bacterial leukotoxin derived from A.
actinomycetemcomitans, gp41 a transmembrane protein found
in HIV, caveolin, apolipoproteins, benzodiazepine, G-protein
coupled receptors, Ca++- and voltage-gated K+ channels as well
as the translocator protein, TSPO (Li and Papadopoulos, 1998;
Vincent et al., 2002; Epand et al., 2005; Jamin et al., 2005; Jafurulla
et al., 2011; Oddi et al., 2011; Singh et al., 2012; Brown et al., 2013;
Lecanu et al., 2013).
It should be noted that not all investigators have observed that
Cdts are dependent upon cholesterol. For instance, cholesterol
loading experiments failed to alter cell susceptibility to C. jejuni
(Eshraghi et al., 2010). Other investigators have reported that
cholesterol depletion did not alter A. actinomycetemcomtans Cdt
internalization (Damek-Poprawa et al., 2012). These findings
are difficult to assess as the experimental protocol and/or
cells utilized varied. For example, in some instances long
exposure times to the cholesterol depleting agent, methyl-β-
cyclodextrin, were employed; this has the risk of altering cell
vitality. Furthermore, cholesterol repletion was not employed as
a control to demonstrate both cholesterol specificity and verify
that viability was not altered.
In addition to binding to cholesterol, it has been demonstrated
that the Cdt holotoxin associates with cholesterol rich membrane
microdomains, as demonstrated by co-localization with GM1
(Boesze-Battaglia et al., 2006). Disruption of lipid rafts by
cholesterol depletion reduces toxin binding, CdtB internalization
and cell susceptibility to Cdt intoxication (Boesze-Battaglia et al.,
2009). Association of Cdt with lipid rafts may be critical to
toxicity for several reasons. First, lipid microdomains have been
shown to serve as a site of attachment for pathogens and provide
a means to concentrate receptors for toxins and thereby increase
binding affinity. Second, lipid microdomains play a key role in
triggering internalization and may provide a means of entry for
the CdtB subunit. Finally, lipid microdomains have been shown
to also serve as signaling platforms; this would put the catalytic
subunit, CdtB, in close proximity to signaling cascades thereby
facilitating their hijacking and involvement in mediating toxicity.
It should be noted that Cdt association with lipid microdomains
and its significance with respect to toxin binding, internalization
and molecular mode of action are a topic of other publications in
this topic area (Boesze-Battaglia et al., 2016; Lai et al., 2016).
Molecular Mode of Action by Which the
Active Cdt Subunit, CdtB, Induces Toxicity
It is generally accepted that exposure of target cells to Cdt
holotoxin leads to irreversible cell cycle arrest and cell death
via apoptosis (Gelfanova et al., 1999; Cortes-Bratti et al., 2001;
Shenker et al., 2001; Ohara et al., 2004). It should be noted
that Cdt-induced cell cycle arrest typically involves arrest in the
G2/M phase, although fibroblasts have been shown to undergo
G1 arrest as well (Frisan et al., 2002). Another interesting
phenomenon is that all cells are not susceptible to Cdt-induced
toxicity (i.e., cell cycle arrest and apoptosis) and further that non-
dividing cells such as non-activated primary human lymphocytes,
Frontiers in Cellular and Infection Microbiology | www.frontiersin.org 6 December 2016 | Volume 6 | Article 168
Scuron et al. Cdt Is a Potent Virulence Factor
macrophages, and mast cells do not undergo apoptosis in the
presence of Cdt (Shenker et al., 2001, 2010, 2014; Smith and
Bayles, 2006). These results are not necessarily surprising as
many microbial toxins exhibit cell specificity. However, in most
instances, cell specificity is attributed to toxin binding to cell
receptors that are unique to the susceptible population(s) and
thereby restrict toxin association and internalization. However,
as discussed earlier, Cdt binding to cells and subsequent CdtB
internalization is dependent upon association and binding to
cholesterol, a ubiquitous membrane component. Consistent
with this finding, we have also demonstrated that Cdt binding
and CdtB internalization occurs in cells that are both Cdt-
susceptible as well as Cdt-resistant (Shenker et al., 2016a).
Thus, restricted susceptibility to Cdt intoxication must be
governed by a mechanism independent of binding and subunit
internalization. In this regard, we propose that cell susceptibility
to Cdt is directly related to the toxin’s molecular mode of
action.
Evidence That Supports CdtB Functioning
As a DNase
The long-standing paradigm accounting for the molecular
mechanism by which Cdt induces cell cycle arrest and ultimately
apoptosis is based upon the active subunit’s (CdtB) ability
to function as a DNase (Lara-Tejero and Galán, 2000). The
evidence in support of CdtB’s ability to function as a DNase and
thereby induce DNA damage has been the subject of numerous
investigations and the focus of several recent review articles
(Guerra et al., 2011b; Jinadasa et al., 2011; Grasso and Frisan,
2015; Taieb et al., 2016). Therefore, we only briefly summarize
the evidence in support of this mode of action which is based
upon the following three lines of investigation: (1) demonstration
of in vitro DNase activity associated with CdtB; (2) nuclear
localization of CdtB; and (3) activation of the DNA damage
response (DDR).
Analysis of Cdt by X-ray crystallography demonstrates that
CdtB exhibits structural similarity with a group of functionally
unrelated metalloenzymes such as DNase I (Dlakic´, 2000; Dlakic,
2001; Nesic et al., 2004; Yamada et al., 2006). Despite the lack
of significant pairwise sequence identity, structural similarity was
predicted on the basis of sensitive multiple sequence alignments
as an extension of an earlier discovery of homology between
the nucleases and bacterial sphingomyelinase (Matsuo et al.,
1996). Analysis of CdtB indicates that its structure can be
superimposed on eukaryote DNase I with an RMSD of 1.62
Å over 141 Cα atoms. A group of six conserved residues that
are found in catalytic sites of DNase I and CdtB superimpose
with an RMSD of 0.34 Å (see Figure 2 for the exact residue
designation in CdtB). Direct evidence of DNase activity leading
to strandbreaks and fragmentation of mammalian DNA has
not been demonstrated to date. However, several investigators
have shown that CdtB isolated from multiple bacteria is able
to denature or relax supercoiled plasmid DNA in vitro (Elwell
and Dreyfus, 2000a; Elwell et al., 2001; Mao and DiRienzo,
2002; Frisan et al., 2003; Nesic et al., 2004). Furthermore,
mutations in putative catalytic amino acids have given rise
FIGURE 2 | Structural similarity between the active sites of CdtB and
IP5P. The superposition was based on conserved residues in the active sites
of CdtB [blue; PDB code 2f2f_B (Yamada et al., 2006)] and IP5P [red; PDB
code 1i9z_A (Tsujishita et al., 2001)]. The two sets of 6 conserved residues are
aligned well, with an RMSD of 0.26 Å. Residue numbers correspond to CdtB
structure. Parts of superimposed structures were clipped out of viewing plane
for clarity.
to proteins with both reduced enzymatic activity and toxicity
(Elwell and Dreyfus, 2000b; Lara-Tejero and Galán, 2000; Nesic
et al., 2004; Hu and Stebbins, 2006; Shenker et al., 2007,
2016a).
CdtB-mediated DNA damage requires that the active Cdt
subunit translocate from the cell surface to the nucleus where
it is able to encounter its enzymatic substrate. Several lines
of investigation have been employed to demonstrate nuclear
localization of CdtB. For example, purified E. coli CdtB was
observed in the nucleus of cells following introduction of
the subunit by electroporation as well as after transfection
and ectopic expression (McSweeney and Dreyfus, 2004);
likewise, Lara-Tejero and Galán (2000) demonstrated transient
expression of C. jejuni CdtB led to nuclear localization.
Moreover, E. coli and A. actinomycetemctomitans CdtB
mutants lacking nuclear localization signals failed to
accumulate in the nucleus and intoxicate cells (Nishikubo
et al., 2003; McSweeney and Dreyfus, 2004). In a more
recent study, Damek-Poprawa et al. (2012) demonstrated
nuclear localization of CdtB following exposure of Chinese
hamster ovary cells (CHO-K1) to A. actinomycetemcomitans
toxin.
While there is a paucity of direct in vitro evidence that
CdtB-associated DNase activity contributes to fragmentation of
mammalian DNA, ample indirect data is available demonstrating
that Cdt-treated cells exhibit signs of damage to cellular DNA.
Evidence in support of CdtB-mediated DNA damage is derived
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from experiments that demonstrate DDR activation in Cdt-
treated cells. The DDR consists of multiple components such
as sensors that detect strandbreaks, kinases and transcription
factors that act as transducers and effector proteins that serve
to delay cell cycle progression and promote DNA repair (Liu
et al., 2016). For example, the presence of DNA strandbreaks
has been shown to lead to formation of the MRN complex
(Mre11, Rad50, andNbs1) which in turn leads to recruitment and
activation of the protein kinase, Ataxia telangiectasia mutated
(ATM), and phosphorylation of the histone H2AX. Cdt’s from
H. ducreyi, C. jejuni, and E. coli have been shown to induce
formation of the MRM complex and/or phosphorylation of
H2AX in HeLa cells, fibroblasts, epithelial cells, and lymphocytes
(Li et al., 2002; Hassane et al., 2003; Bielaszewska et al.,
2005; Liyanage et al., 2010; Dixon et al., 2015). Additionally,
Cdt-treated cells exhibit activation of the G2 checkpoint in
a manner that is consistent with other agents known to
induce DNA damage and activation of the DDR. Specifically,
several investigators have demonstrated that Cdt treated cells
exhibit increased levels of the active kinase Chk2 along with
hyperphosphorylation of both (inactive) CDC25 phosphatase
and the cyclin-dependent kinase CDK1 (Sert et al., 1999; Cortes-
Bratti et al., 2001; Li et al., 2002; Sato et al., 2002; Yamamoto
et al., 2004). In the absence of repair, activation of the G2
checkpoint should lead to apoptosis in addition to cell cycle
arrest; an observation consistent with the known effects of
Cdt. However, it has also been noted that if cells survive
Cdt intoxication, CdtB-mediated DNA damage may contribute
to genetic instability and thereby may promote carcinogenesis
(Guidi et al., 2013).
It should be noted that in almost every instance, experiments
demonstrating DNase activity, nuclear localization of CdtB as
well as activation of the DDR were done under conditions of
exposure to relatively high levels (microgram) of toxin as well
as with “non-physiologic” routes of exposure. Interestingly, we
and several other investigators have demonstrated that CdtB
exhibits low DNase activity when compared with bovine DNase
I (<0.01%, Elwell and Dreyfus, 2000a; Shenker et al., 2001;
Haghjoo and Galán, 2004; Nesic et al., 2004) perhaps explaining
the requirement for employing high toxin doses. Additionally, it
should be noted that several of these studies failed to differentiate
between DNA damage due to direct CdtB associated DNase
activity and that due to indirect effects resulting from caspase
mediated activation of endogenous DNase; the latter is supported
by our own studies on lymphocytes and HeLa cells (Gelfanova
et al., 1999; Shenker et al., 2001; Nalbant et al., 2003; Thelastam
and Frisan, 2004). Specifically, inhibition of the apoptotic cascade
by over expression of Bcl-2 or with the use of a caspase-3 inhibitor
results in suppression of the DDR with no effect on Cdt-induced
cell cycle arrest. Moreover, under conditions optimized to expose
cells to the minimal amount of Cdt necessary to induce maximal
G2 arrest within 24 h (and apoptosis at 48 h), we were unable
to demonstrate DDR activation in lymphoid cells at 4 h. DDR
activation could only be induced following longer exposures to
higher Cdt concentrations for both lymphocytes and HeLa cells
(Shenker et al., 2016a). These results collectively argue for DDR
activation, at least in lymphocytes, to be the result of late events,
and likely associated with enzymatic degradation of DNA due to
activation of the apoptotic cascade.
Evidence That CdtB Functions As a
Phosphatidylinositol-3,4,5-Triphosphate
(PIP3) Phosphatase
As noted above, the bias in the literature supporting a role
for CdtB associated DNase activity as the underlying mode of
action function was based, in part, on structural homology with
DNase I. This relationship obscures the fact that CdtB’s protein
fold and reaction mechanism are also shared with a number of
metalloenzymes (Dlakic´, 2000; Dlakic, 2001). CdtB structure can
also be superimposed on inositol polyphosphate-5-phosphatase
(IP5P), another member of this superfamily, with an RMSD of
1.63 Å over 121 Cα atoms, which is similar to that observed
with DNase I. The six conserved residues in the catalytic site
of CdtB (Yamada et al., 2006) and IP5P (Tsujishita et al., 2001)
superimpose with an RMSD of 0.26 Å (Figure 2), which is
slightly better than the alignment of those same residues between
CdtB and DNase I. This is not surprising since CdtB, IP5P, and
DNase are all phosphoesterases (Dlakic´, 2000; Dlakic, 2001); the
specific function of each of these enzymes is largely dependent
upon accommodation of substrates within their respective active
site (Shenker et al., 2016a). Over the past several years, we
have generated evidence for a new paradigm to account for the
molecular mode of action by which A. actinomycetemcomitans
CdtB intoxicates cells. Central to this mechanism is CdtB’s ability
to function as a lipid phosphatase similar to IP5P. As a result, Cdt
is then able to perturb the critically important signaling pathway,
the phosphoinositide 3-kinase (PI-3K) signaling pathway, that
regulates cell survival, growth and a variety of functions that are
cell type specific.
PIP3 is now recognized for its critical role in regulating cell
growth, proliferation, and survival, among others (Kraub and
Haucke, 2007; Sasaki et al., 2007; Buckler et al., 2008; Huang
and Sauer, 2010). To be effective as a second messenger, PIP3
is maintained at low baseline levels which may increase rapidly
in response to signals that typically originate at the plasma
membrane leading to PI-3K activation. PIP3 levels are tightly
regulated by three degradative enzymes: PTEN, SHIP1, and
SHIP2 (Krystal, 2000; March and Ravichandran, 2002; Seminario
and Wange, 2003). PTEN (ptase and tensin homolog deleted
on chromosome ten), hydrolyzes PIP3 to PI-4,5-P2. SHIP1
(SH2-containing inositol phosphatase) and SHIP2 are inositol
5-phosphatases (IP5P); SHIP2 is ubiquitously expressed while
SHIP1 is found in a limited subset of cells which includes immune
cells. Both SHIP enzymes hydrolyze PIP3 to PI-3,4-P2 and
inositol 1,3,4,5-tetrakisphosphate to inositol 1,3,4 triphosphate.
The PI-3K/PIP3/Akt signaling pathway is regulated collectively
by the action of these synthetic and degradative enzymes. Of
particular relevance to Cdt toxicity, we have shown that the active
Cdt subunit, CdtB, exhibits potent PIP3 phosphatase activity
similar to that of SHIP.
In order to first establish a clear association between Cdt-
mediated toxicity and CdtB’s ability to function as a PIP3
phosphatase, an extensive analysis of CdtB mutants was carried
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out. Mutants were designed to target residues predicted to be
part of the active site and/or involved in substrate binding.
Additional residues were targeted because they are conserved
in both CdtB and IP5P but not in DNase I; other residues
were targeted because they are conserved in IP5P and DNase
I but not in CdtB. Analyses of this array of CdtB mutants
clearly demonstrate a strong correlation between Cdt toxicity
and retention of CdtB PIP3 phosphatase (Shenker et al., 2016a).
Another key finding was that some mutants exhibited improved
DNase activity; however this increase in enzymatic activity did
not correlate with increased cytotoxicity suggesting that DNase
function of CdtB is secondary to the lipid phosphatase function.
This is consistent with the notion that a single enzyme is unlikely
able to equally accommodate two substrates, such as DNA and
lipid phosphates, as they significantly differ in both size and
overall structure. Nonetheless, both molecules contain phosphate
esters and are hydrolyzed, to some extent, by multiple enzymes
such as those that comprise the superfamily that includes both
CdtB and DNase I (Dlakic´, 2000).
CdtB Induces PI-3K Signaling Blockade
Mutation analysis discussed above is consistent with the notion
that CdtB perturbs the PI-3K/PIP3/Akt signaling pathway
(Shenker et al., 2007, 2014; Boesze-Battaglia et al., 2015). More
recent studies demonstrate that CdtB perturbs this signaling
pathway within a few hours of exposure to Cdt; these changes
include a decline in PIP3 levels and a concomitant increase in
PI-3,4-P2, the enzymatic product of PIP3 degradation. Similar
changes were observed for human peripheral bloodmononuclear
cells (HPBMC) activated by mitogen (Shenker et al., 2016a).
PI-3K activation leads to not only PIP3 production, but
also phosphorylation of the critical downstream kinase, Akt;
phosphorylation of Akt (pAkt) leads to its activation. Thus, it is
noteworthy that Shenker et al. (2016a) observed that Cdt-treated
lymphocytes not only exhibit PIP3 depletion, but also significant
decreases in pAkt; this change in phosphorylation status was
accompanied by a concomitant decrease in its kinase activity. A
downstream target of pAkt is another kinase, GSK3β. Activation
of Akt typically leads to phosphorylation and inactivation of
GSK3β (pGSK3β). Indeed toxin treated cells were found to
exhibit a reduction in the phosphorylation of GSK3β; reduced
pGSK3β was accompanied by an increase in its kinase activity.
This observation is critical since GSK3β, initially discovered as
an inhibitor of glycogen synthase, has recently been implicated in
the regulation of cell functions associated with inflammation, cell
proliferation, and apoptosis, among others (Luo, 2009; Rayasam
et al., 2009). It is noteworthy that pre-treatment of cells with
GSK3β inhibitors reduced their susceptibility to Cdt intoxication;
these results are consistent with a mode of action involving Cdt-
mediated PI-3K signaling blockade, suppression of cell growth
and promotion of cell death (Buckler et al., 2008; Yuan and
Cantley, 2008; Huang and Sauer, 2010).
CdtB associated lipid phosphatase activity and PI-3K blockade
also contributes to toxicity in non-lymphoid cells. Under
conditions optimized to induce cell cycle arrest at 24 h, Shenker
et al. (2016a) observed that Cdt holotoxin containing CdtBWT
induced phosphorylation of H2AX at 16 h. These findings are
consistent with results reported by other investigators following
exposure to significantly higher concentrations of toxin (Li
et al., 2002; Fahrer et al., 2014). In contrast, substitution of
CdtB wildtype with a CdtB mutant that was shown to retain
phosphatase and no DNase activity (CdtBA163R), failed to induce
phosphorylation of H2AX; this mutant did induce G2 arrest as
observed with CdtBWT. These results clearly demonstrate that
HeLa cells undergo Cdt-induced G2 arrest in the absence of
CdtB-associated DNase activity and detectable DDR activation.
It is noteworthy that these results are consistent with those of
Sert et al. (1999) who reported that toxin-treated HeLa cells
underwent G2 arrest in a manner that was independent of DNA
damage. Interestingly, Shenker et al. (2016a) demonstrated that
toxin comprised of CdtBmutants which retain DNase activity but
deficient in PIP3 phosphatase activity lost the ability to induce
HeLa cells to undergo G2 arrest; H2AX phosphorylation was
also not observed in these cells. Cdt induced PI-3K blockade was
further corroborated by the observation that GSK3β inhibitors
could block toxin-induced G2 arrest in HeLa cells as described
above for lymphoid cells (Shenker et al., 2016a).
Shenker et al. (2016a) did not rule out a possible role for
DNase activity in mediating some aspects of Cdt toxicity. First,
it is important to emphasize that PIP3 phosphatase activity has
only been demonstrated for A. actinomycetemcomitans Cdt; it is
possible that other Cdts are more dependent upon DNase activity
to induce toxicity. Second, cells that exhibit resistance to Cdt
and require exposure to high doses of Cdt in order to become
intoxicated may indeed be responding to cellular alterations
that are the result of CdtB associated DNase activity (Deng
et al., 2001; Li et al., 2002; Guerra et al., 2011a). One argument
against a primary role for Cdt-mediated PI-3K blockade is the
observation that Saccharomyces cerevisiae are susceptible to Cdt-
induced cell cycle arrest (Hassane et al., 2001; Matangkasombut
et al., 2010); these cells do not synthesize PIP3. Nonetheless,
S. cerevisiae do synthesize a myriad of phosphatidylinositol
mono and di-phosphates; these phosphoinositides regulate many
cell functions including growth and survival (Gardocki et al.,
2005; Strahl and Thorner, 2007). To date there is no evidence
demonstrating whether CdtB is able to alter any of these moieties
in S. cerevisiae. Another area of controversy involves the link
between the PI-3K pathway and regulation of cell size. This
linkage lead Frisan et al. (2003) to suggest a critical role for
PI-3K signaling in the development of cellular distension, a
hallmark of Cdt toxicity; however, these authors did not provide
evidence for PI-3K activation. It should also be noted that
others have shown that there is no linkage between PI-3K
signaling, cell size regulation and cell cycle arrest (Lee et al.,
2007).
EVIDENCE THAT Cdt EXPRESSION IS
CRITICAL TO DISEASE
As noted in Table 1, Cdts have been identified in a wide range
of pathogenic species that infect a number of host tissues often
in association with the development of significant inflammation.
To date there is limited evidence that directly implicates Cdts
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as a virulence factor responsible for the molecular pathogenesis
of disease in response to infection by Cdt-producing pathogens.
Most evidence is circumstantial and based upon the presence
of Cdt genes and/or protein in clinical isolates from pathogenic
bacterial strains (summarized in Table 1). The identification
of these Cdt-producing pathogens was initially based upon
evaluation of bacterial extracts or supernatants for the presence
of toxic activity and in some instances by genotyping for the
presence of Cdt genes. More recently, several investigators have
provided direct evidence suggesting that the pathogenicity of
some pathogens is indeed linked to their ability to produce
biologically active Cdt and thereby induce cytotoxic effects on
host tissue. The evidence suggesting that Cdt is a crucial virulence
factor is summarized in this section.
E. coli Cdt
The presence of Cdt in clinical isolates of E. coli 0128 and
055:K59:H4 was first reported in the 1980s’ in association with
gastroenteritis (Anderson et al., 1987; Johnson and Lior, 1988b).
Although a causal relationship was not established, the authors
suggested that Cdt may have encephalopathic potential based
on clinical presentation of disease in a 3-year old patient. Since
these initial observations, there have been numerous reports
demonstrating the presence of Cdt in significant portions of
clinical isolates of enteropathogenic E. coli (reviewed in Smith
and Bayles, 2006); five cytolethal distending toxin sequence
variants were detected in these E. coli strains (Clarke, 2001;
Pickett et al., 2004; Hinenoya et al., 2009) and more recently,
Shiga toxin-producing E. coli (Clarke, 2001; Janka et al., 2003;
Bielaszewska et al., 2004). With respect to the latter, the authors
suggested that Cdt-positive strains were significantly associated
with clinical symptoms such as hemolytic uremic syndrome
and watery diarrhea. In other studies, a putative role for
Cdt in EPEC infections could not absolutely be determined
because of the co-expression of other virulence factors by
clinical isolates or in some instances, the low incidence rate
of Cdt among isolates (Albert et al., 1996; Okeke et al., 2000).
Additionally, Cdt-producing E. coli from serogroup 086:K61
were reported as a possible cause of mortality in birds (Foster
et al., 1998). Culture supernatants from several of these strains
were also tested on mammalian cell cultures and found to cause
distinct morphological changes, cell cycle arrest and cell death
implicating Cdt effects on vascular endothelium as well as on
epithelial cells of the urinary and/or gastrointestinal tracts. The
significance of these in vitro findings in the context of virulence
and disease pathogenesis is discussed in the next section.
Shigella spp. Cdt
The production of Cdt was also described in Shigella dysenteriae
type 2 and S. boydii type 7 strains. Similar to E. coli Cdts,
Shigella Cdt was implicated in inflammatory responses of the
gut (Johnson and Lior, 1988b). Okuda et al. (1997) provided the
first in vivo experimental evidence of the diarrheagenicity of the
S. dysenteriae Cdt in a suckling mouse model. Cdt-containing
culture supernatant and partially purified Cdt preparations
induced watery diarrhea. The incidence of loose/watery feces
in mice subjected to Cdt was much higher as compared
to animals given supernatants from Cdt-negative bacteria
strains. The correlation between the amount of Cdt in the
preparations and the diarrhea score, expressed as percentage of
the diarrhea-positive animals in test groups, demonstrated the
diarrheagenicity potential of Cdt.
Campylobacter spp. Cdt
A cytotoxic factor, later defined as Cdt, was detected in culture
filtrates of numerous C. jejuni, C. coli, and C. laridis strains
recognized as enteric pathogens in human diarrheal disease as
well as C. fetus subs. fetus associated with bovine abortion.
Exposure of epithelial cells to Campylobacter spp. Cdt resulted in
cell elongation, distention, and subsequent death within 96–120
h. Homologous rabbit antitoxin neutralized Cdt activity (Johnson
and Lior, 1988a; Mizuno et al., 1994). C. jejuniCdt-induced HeLa
and Caco-2 cell death following cell cycle arrest in early G2/M
phase (Whitehouse et al., 1998; Jain et al., 2009).
Cell-free preparations from C. jejuni strains 81–176 and
NCTC 11168 containing the CdtB subunit inactivated by
insertional mutation had either much lower toxicity or were
completely inactive in HeLa cell cytotoxicity assays. Following
intragastric inoculation of adult severe immunocompromised
(SCID) mice, C. jejuni CdtB-negative mutants showed similar
intestinal colonization but greatly reduced invasiveness into
blood, liver, and spleen as compared to isogenic wild-type strains.
Moreover, descending colons of SCID mice were damaged in the
presence of the active toxin (Purdy et al., 2000). Wild-type C.
jejuni strain but not its Cdt-lacking isogenic mutant was capable
of causing more progressive gastritis and proximal duodenitis
in a mouse oral gavage model (Fox et al., 2004a) and in the
suckling mouse model (Jain et al., 2008). It has been shown
that Cdt-producing C. jejuni strains exhibit greater adherence
to and invasion of epithelial cells than mutants lacking Cdt
activity. Fox et al. (2004a) reported that production of Cdt may
facilitate bacterial escape of immune surveillance by inducing
cell cycle arrest and apoptosis in lymphocytes. Unlike the wild-
type, C. jejuni mutant lacking Cdt activity was eliminated
from immunocompetent mice; the bacteria persisted in NF-κB-
deficient mice.
Cdt was also detected in sonicates prepared from multiple
Helicobacter hepaticus strains, closely related to Campylobacter
species. These toxin preparations were shown to display
cytopathic effects on HeLa cells similar to C. jejuni Cdt (Young
et al., 2000b). The production of biologically active Cdt, as
confirmed by in vitro assays using HeLa, Caco-2, and HCA-
7 cells, was also reported in a number of other Helicobacter
species, including human pathogens H. pullorum (Young et al.,
2000b; Varon et al., 2014), H. canis (Chien et al., 2000), and
H. cinaedi (Taylor et al., 2003). Interestingly, to date Cdt is the
only known virulence factor present in H. hepaticus (Liyanage
et al., 2010). Furthermore, a H. hepaticus isogenic mutant
of the Cdt gene cluster had diminished capacity to induce
lesions in the gut of C57BL/6 interleukin 10(−/−) mice in a
model of inflammatory bowel disease. The animals infected with
wild-type H. hepaticus developed severe mucosal hyperplasia
accompanied by inflammation of the lamina propria, while the
mice colonized with Cdt mutant exhibited only mild, patchy
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mucosal inflammation (Young et al., 2004; Pratt et al., 2006).
Additionally, Ge et al. (2005) showed that the presence of
biologically active Cdt is crucial for persistent colonization of
H. hepaticus in cecum, colon and jejunum of out bread Swiss
Webster mice.
H. ducreyi Cdt
H. ducreyi was shown to secrete a soluble cytotoxin that leads to
the death of both HeLa and Hep-2 cells; it was further proposed
that this toxin was a putative virulence factor contributing to
the pathogenicity of this bacterium (Lagergård, 1992; Purvén
and Lagergard, 1992; Lagergård and Purven, 1993; Purvén et al.,
1995). This virulence factor was later identified as a product
of the Cdt gene cluster. It should also be noted that in several
studies, 64–89% of clinical isolates tested contained the Cdt genes
(Purvén et al., 1995; Frisk et al., 2001). Culture supernatant
obtained from a strain of H. ducreyi lacking the Cdt genes
was unable to kill epithelial cells (Cope et al., 1997; Stevens
et al., 1999). Expression of all three H. ducreyi recombinant Cdt
subunits in E. coli was necessary to exert toxic effects on HEp-2
cell cultures (Frisk et al., 2001). Cortes-Bratti and co-investigators
(Cortes-Bratti et al., 1999) demonstrated cell cycle arrest and
epithelial cell death in the presence of H. ducreyi Cdt suggesting
that the toxin may contribute to the development and chronic
nature of the ulcerative lesions associated with chancroid.
Further, in vitro and in vivo studies provided compelling
evidence for a role of Cdt as a bacterial virulence factor.
Hemolysin-deficient H. ducreyi mutant producing Cdt elicited
similar inhibitory and apoptotic effects on peripheral blood
mononuclear cells and Jurkat cells as its isogenic parent
(Gelfanova et al., 1999). However, when the H. ducreyi
CdtA, CdtB, and/or CdtC subunit(s) were deleted, the toxin
preparations exhibited lower (in case of cdtA mutant) or no
cytotoxicity for HeLa cells. Surprisingly, no change in virulence
of H. ducreyi Cdt mutants was observed in a temperature-
dependent rabbit model (Lewis et al., 2001). Isogenic H. ducreyi
CdtCmutant and its parent clone were also shown to be similarly
virulent in pustule formation in the early stages of chancroid
in human volunteers (Young et al., 2001). Nonetheless, purified
H. ducreyi CdtA, CdtB, and CdtC, injected as a complex in
rabbit skin, caused dose-dependent erythema and edema as well
as inflammatory cell infiltration and dilatation of blood vessels.
Individual protein subunits had no pathological effect on rabbit
skin following intradermal injection (Wising et al., 2002).
A. actinomycetemcomitans Cdt
Cdt with amino acid sequence similar to H. ducreyi Cdt was
also detected in Actinobacillus (currently Aggregatibacter)
actinomycetemcomitans culture supernatants (Sugai et al.,
1998; Ahmed et al., 2001; Yamano et al., 2003). All
A. actinomycetemcomitans members of the restriction fragment
length polymorphism (RFLP) group II cluster (DiRienzo and
McKay, 1994), which was shown to be associated with the
conversion in young children from periodontal health to
localized aggressive periodontitis (LAP; Mayer et al., 1999),
contained a complete cdt gene locus (Mayer et al., 1999).
The toxin was shown to cause cell distention and cell cycle
arrest in HeLa cells. The combination of all three recombinant
A. actinomycetemcomitans Cdt protein subunits expressed in
E. coli was necessary to induce HEp-2 cell cycle arrest (Akifusa
et al., 2001). Exposure of epithelial cells to individual subunits
failed to block cell cycle progression.
Human lymphocytes were found to be exquisitely sensitive to
A. actinomycetemcomitans Cdt; small quantities (picogram) of
toxin were capable of inducing cell cycle arrest and apoptosis
within 24 and 48 h, respectively (Shenker et al., 2001, 2004).
Similar results were reported by Nalbant et al. (2003). In contrast,
to the effect of Cdt on proliferating lymphoid cells, the toxin
failed to kill human monocytes and macrophages (Shenker et al.,
2014, 2015). Instead, exposure to Cdt resulted in the synthesis
and release of pro-inflammatory cytokines. Likewise, Akifusa
(Akifusa et al., 2001) demonstrated that Cdt induced IL-1β, IL-
6, and IL-8 cytokine production in human peripheral blood
mononuclear cells (PBMCs).
The importance of Cdt as a potential
A. actinomycetemcomitans virulence factor was underscored
by its role in the induction of receptor activator of NF-κB
ligand (RANKL) expression in human gingival fibroblasts and
periodontal ligament cells. This is a critical finding as RANKL
expression is associated with osteoclast differentiation and
thereby contributes to regulation of bone resorption. Thus,
the possibility exists that Cdt-induced expression of RANKL
may be involved in the pathogenesis of periodontitis (Mogi,
2004). Purified recombinantH. ducreyi Cdt also induces RANKL
expression in osteoclasts. Furthermore, pretreatment of A.
actinomycetemcomitans wild-type extract with Cdt neutralizing
antibody abolished RANKL expression (Belibasakis et al., 2005a).
The detrimental effect of the A. actinomycetemcomitans Cdt
on periodontal tissues was confirmed using an in vivo rat
model. Topical application of Cdt to the gingival sulcus of rats
resulted in junctional epithelial tissue abrasion. Interestingly,
animals treated with both wild-type and mutated Cdt exhibited
neutrophil infiltration. However, epithelial cell damage occurred
only in rats treated with wild-type Cdt (Ohara et al., 2011).
Damaging effects of wild-type A. actinomycetemcomitans Cdt on
gingival epithelia were also detected in rat and human gingival
explants (Damek-Poprawa et al., 2011, 2013).
Salmonella enterica subsp. Enterica
Serotype Typhi (S. Typhi) Cdt
As noted earlier, the CdtB gene was also detected in S. Typhi
(Parkhill et al., 2001; Haghjoo and Galán, 2004). While other
Salmonella serovars cause self-limiting gastroenteritis, S. Typhi
causes persistent and life-threatening systemic disease. S. Typhi
produces a unique toxin, typhoid toxin, in which the active (A)
unit is comprised of two subunits: CdtB and PltA, a homolog
of the active subunit of pertussis toxin. Song et al. (2013)
demonstrated that systemic administration of typhoid toxin into
mice induced many of the symptoms commonly observed in the
early stages of typhoid fever. Also, a non-typhoidal Salmonella
enterica serovar Javiana was found to express Cdt; this organism
is associated with gastrointestinal illnesses in humans, cattle,
birds, and reptiles (Mezal et al., 2014). Biologically active S.
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Javiana Cdt was shown to increase invasiveness of the bacteria in
HeLa cell cultures. These observations suggest a role for CdtB as
an important virulence attribute of Salmonella. spp. (Mezal et al.,
2014).
Cdt FUNCTIONS AS A TRI-PERDITIOUS
VIRULENCE FACTOR BY TARGETING
HOST DEFENSES
The role of a virulence factor is defined, in part, by key
features such as its ability to associate with a specific cell(s)
and its molecular mode of action. Taking into account that
Cdt-producing bacteria typically infect mucocutaneous tissue, we
now propose that Cdt contributes tomicrobial virulence by virtue
of its ability to function as a tri-perditious toxin as it targets host
defenses at three levels (see Figure 1): (1) promotion of infection
by altering barrier protection through modulation of epithelial
cell growth and survival, (2) promotion of inflammatory
responses through activation of the inflammasome leading to
cytokine maturation and release, and (3) impairment of acquired
immunity and as a consequence diminished immune elimination
by inhibiting T- and B-cell proliferation and survival. In this
section, we discuss the evidence that Cdt targets these three host
systems.
Cdt is capable of intoxicating a wide range cells and/or cell
lines, regardless of microbial source. Intoxication of proliferating
cell populations is characterized by distinct morphological
alterations, inhibition of cell growth most commonly associated
with G2 arrest of the cell cycle and ultimately cell death resulting
from activation of the apoptotic cascade (Jinadasa et al., 2011).
In contrast, non-proliferating cells, such as macrophages, mast
cells, and osteoclasts are resistant to Cdt-induced cell death;
however, these cells are susceptible to Cdt-mediated alterations
in cell function. The ability of a single toxin to affect multiple cell
types is consistent with current understanding of the underlying
mechanism of Cdt-host cell interactions which is dependent
upon binding to cholesterol, a ubiquitous membrane component,
as opposed to hijacking a unique receptor associated with a
specific cell type. As noted earlier, Cdt from C. jejuni and S.
Typhi are not dependent upon cholesterol binding. Moreover,
the ability to intoxicate multiple cell types leading to different
outcomes is also consistent with the proposed paradigm shift
in which CdtB functions as a PIP3 phosphatase and targets the
key PI-3K signaling pathway. As PI-3K is a signaling pathway
commonly used by most cells to regulate a variety of functions,
blockade of this pathway will lead to alterations involving a
range of cell activities which are ultimately defined by the unique
programming of each individual cell type. It should also be noted
that hijacking of the PI-3K signaling cascade is also consistent
with Cdt’s association with cholesterol in the context of lipid rafts.
These membrane moieties have been shown to serve as platforms
for a number of signaling cascades in which substrates and critical
components accumulate. It should also be noted that lipid rafts
and sphingomyelin-controlled protein scaffolds are important
for lipid signaling in cells; thus the observations of Carette et al.
(2009) are critical as they demonstrate that cells deficient in
sphingomyelin synthase are also resistant to Cdt intoxication.
These results further suggest that lipid rafts are important for
CdtB entry into cells.
Cdt Impairs Epithelial Barriers
Epithelial cells constitute the mechanical barrier between the
host and an environment often teeming with microbes; thus,
perturbation of protective epithelial layers exposes underlying
tissues to bacteria and their products. As noted above, Cdt-
producing bacteria identified to date are pathogens that exhibit
an affinity to colonize mucocutaneous tissue such as oral,
gastrointestinal, urinary, and respiratory tracts (Jinadasa et al.,
2011). Moreover, the subsequent development of disease in these
mucocutaneous niches is clearly the result of sustained infection
and inflammation. For example, Cdt-producing Campylobacter,
Escherichia, Helicobacter, Shigella, and Salmonella species
account for a majority of food- and water-borne infectious
diarrheal illnesses in humans (Tauxe, 1997; Ge et al., 2008;
Jinadasa et al., 2011) and animals (Black et al., 1988; Dassanayake
et al., 2005a; Johnson et al., 2007). Epithelial cells intoxicated with
Cdt undergo G2 arrest leading to apoptosis (Ceelen et al., 2006a;
Smith and Bayles, 2006; Liyanage et al., 2010, 2686/id). Cdt is
also responsible for decreased intestinal epithelial cell adherence
that results from alteration of actin cytoskeleton and disturbance
of focal adhesion and microtubule network (Schulze et al., 1998;
Varon et al., 2014).
In the oral cavity, highly proliferative primary human gingival
epithelial cells (HGEC) are sensitive to the toxin produced by
A. actinomycetemcomitans Cdt and exhibit a response similar
to that observed with a Cdt-treated immortalized human oral
vestibular epithelial cell line (GMSM-K; Kang et al., 2005;
Kanno et al., 2005; Damek-Poprawa et al., 2011). Following
intoxication, HGEC undergo rapid G2 arrest. As noted earlier,
ex vivo experiments demonstrated that Cdt altered the integrity
of the gingival epithelial barrier; damage included detachment of
the keratinized outer layer, distention of spinous and basal cells
in the oral epithelium, disruption of rete pegs, and dissolution
of cell junctions (Damek-Poprawa et al., 2013). Likewise, the
genital pathogenH. ducreyi, a well-established cause of a sexually
transmitted chancroid (Abeck et al., 1997), has recently emerged
as a major etiologic agent in chronic limb ulceration similar to
yaws in the Pacific region and Africa. Infection with H. ducreyi
occurred following trauma to the epithelial layer and Cdt-
induced epithelial cell death was a contributing factor in slow
healing of lesions (Lewis and Mitja, 2016).
Cdt Impairs Acquired Immunity
To date there have been few studies that assess immunity to
Cdt following natural or experimental exposure. Nonetheless,
studies on A. actinomycetemcomitans Cdt, as well as the closely
related Cdt from H. ducreyi, indicate that anti-Cdt responses in
patients with LAP or chancroid who do harbor the respective
pathogens, generally produce low levels of antibody.Moreover, in
most instances where antibodies were detected, the incidence and
potency of Cdt-neutralizing antibodies was low (Lagergård and
Purven, 1993; Xynogala et al., 2009; Ando et al., 2010; Lundqvist
et al., 2010). The authors concluded that either the holotoxin is
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not immunogenic or its ability to function as an immunotoxin
interferes with the host’s ability to respond to it as an immunogen.
These authors also suggested that the inability to neutralize Cdt
likely contributes to failure of the host’s immune system to
eliminate the microbe and thereby limit disease. Anecdotally,
we have assessed >20 LAP patient sera and 20% were capable
of toxin neutralization (unpublished data) and further, we have
also generated >100 anti-Cdt monoclonal antibodies and found
that only five were capable of toxin neutralization. In contrast,
Wising et al. (2002) has demonstrated that immunization of
rabbits with a toxoid prepared from Cdt results in a robust
immune response capable of toxin neutralization. These results
further support the notion the Cdt functions as an immunotoxin;
although these latter observations could also be the result of
novel epitopes becoming available when challenged with the
toxoid. Finally, it should be noted that S. Typhi establishes
persistent infection; this is an observation consistent with the
action of an immunosuppressive toxin. As noted above, typhoid
toxin is comprised of active subunits of both pertussis toxin
and Cdt. It has been suggested that the immunomodulatory
activity of the CdtB component of the typhoid toxin may be
a contributing factor to this persistent infection (Haghjoo and
Galán, 2004). Moreover, injection of typhoid toxin into mice
induces many of the early symptoms associated with typhoid
fever as well as a significant reduction in immune cells (Song
et al., 2013).
Consistent with the discussion above, it is now well-
established that lymphocytes, both B and T, are among the
most susceptible cells to Cdt. We first demonstrated that
treatment of Jurkat cells and mitogen activated HPBMC with
low levels (picogram) of A. actinomycetemcomitans Cdt resulted
in inhibition of proliferation and G2 arrest within 24 hr;
interestingly, these cells did not exhibit cellular distension as
has been characterized for other cells (Shenker et al., 1999,
2000). Exposure to these same doses of Cdt resulted in apoptosis
after 48 h. Nalbant et al. (2003) observed that Cdt holotoxin
could also inhibit HPBMC proliferation; mutants lacking the
CdtB subunit were deficient in this inhibitory effect. Likewise,
Gelfanova et al. (1999) demonstrated that H. ducreyi Cdt also
inhibited proliferation and induced apoptosis in these same cell
populations. In 2001, Mooney et al. (2001) demonstrated that
lysates of C. upsaliensis contained Cdt which could also induce
G2 arrest in human T-cells. These findings have been confirmed
by other investigators as well (Cortes-Bratti et al., 2001; Svensson
et al., 2001; Sato et al., 2002). Xu et al. (2004) also demonstrated
that monocyte-derived dendritic cells treated withH. ducreyi Cdt
did not exhibit cytokine responses or support T-cell proliferation;
these findings lead these authors to propose that the toxin not
only impairs lymphocyte proliferation and survival, but may also
interfere with early stages of the developing immune response.
Cdt Promotes Pro-Inflammatory
Macrophage Responses
Innate immunity represents the first line of defense against
microbial pathogens. A key component in the activation of
innate immune responses involves Toll-like receptors (TLRs);
recognition of microbial products by TLRs leads to the
production of pro-inflammatory cytokines. In general, this pro-
inflammatory response protects the host. However, excessive or
prolonged release of pro-inflammatory cytokines may eventually
turn this protective function to one that contributes to overt
tissue damage. Conversion from a protective to destructive
role is of particular relevance as many diseases associated
with Cdt-producing pathogens involve persistent infection along
with a robust inflammatory response. Periodontal disease, for
example, is considered to be a bacterial-induced inflammatory
disorder culminating in the destruction of tooth-supporting
tissues. One form of periodontal disease, LAP, is associated
with infection by Cdt-producing A. actinomycetemcomitans
(Xynogala et al., 2009). Experimental and clinical investigations
into the pathogenesis of LAP demonstrate the presence of high
levels of pro-inflammatory cytokines within the periodontium
(Ando et al., 2010). In addition to tissue damage which ultimately
contributes to tooth loss, the degraded proteins along with
hemin may serve the nutritional needs of the bacteria to
further promote their growth and survival (Hajishengallis et al.,
2012).
As noted above, there is general consensus that macrophage
survival is not altered by Cdts (Svensson et al., 2001; Shenker
et al., 2014); however, macrophages are indeed susceptible to
Cdt intoxication. Cdt has been shown to perturb PI-3K signaling
in human monocytes and macrophages derived from the THP-
1 cell line. Specifically, Cdt treatment resulted in decreases
in Akt and GSK3β phosphorylation; concomitant alterations
in kinase activity was observed with lymphocytes (Shenker
et al., 2014). Exposure to Cdt did not lead to macrophage
death; however, the toxin did induce a pro-inflammatory
cytokine response characterized by increased expression and
release of IL-1β, IL-18, TNFα, and IL-6. Interestingly, Cdt also
augmented the pro-inflammatory cytokine response stimulated
by TLR-2, -3, or -4 agonists. These findings are consistent
with CdtB-mediated PI-3K bockade, GSK3β activation and
NF-κB activation; the latter is known to lead to increased
expression of pro-inflammatory cytokines (Arbibe et al., 2000;
Guha and Mackman, 2002; Hazeki et al., 2007; Molnarfi
et al., 2007; Brown et al., 2010; Antoniv and Ivashkiv,
2011).
Release of mature IL-1β and IL-18 is known to be dependent
upon caspase-1 activation; maturation of caspase-1 is dependent
upon the activation of inflammasomes. Indeed, the Cdt-
induced pro-inflammatory response was also observed to be
dependent upon activation of the NLRP3 inflammasome.
Shenker et al. (2015) have demonstrated Cdt-mediated
inflammasome activation is dependent upon toxin-induced
increases in extracellular ATP, activation of the purinergic
receptor, P2X7 and K+ eﬄux. It should also be noted that
Belibasakis and Johansson (2012) have shown that treatment
of human monocytes with A. actinomycetemcomitans leads
to increased expression of NLRP3; however, they reported
that this effect was not dependent upon Cdt. The authors
did not indicate if inflammasome activation occurred
in toxin treated cells or whether mature cytokine was
secreted.
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SUMMARY
In this review, we have addressed a key issue relevant to the
role of Cdt as a virulence factor. Many cells have been shown to
be susceptible to Cdt intoxication; however, it should be noted
that cells do exhibit differential susceptibility to Cdt in terms
of absolute sensitivity. Specifically, lymphocytes and possibly
epithelial cells represent the highly sensitive side of the spectrum
requiring picogram to nanogram quantities of Cdt, while HeLa
cells and fibroblasts represent the least sensitive side typically
requiring microgram quantities of toxin; macrophages exemplify
cells of moderate sensitivity requiring nanogram quantities. We
propose that differential cell sensitivity to Cdt reflects variance
in the dependence of cells on PI-3K signaling for cell survival,
growth and/or cell function. Moreover, toxin susceptibility is
likely influenced by baseline levels of intracellular PIP3 which
reflect the state of activity of this signaling pathway. Indeed,
we have previously demonstrated that lymphoid susceptibility
to Cdt correlates with baseline PIP3 levels; lymphoid cells with
high levels of PIP3 and active PI-3K signaling exhibit heightened
susceptibility to Cdt vs. those with low levels of the lipid
second messenger and relatively inactive signaling exhibited
reduced sensitivity (Shenker et al., 2016b). In conclusion,
we propose that Cdt functions as a tri-perditious virulence
factor as it targets host defenses in three ways: (1) altering
barrier protection (via epithelial toxicity) thereby promoting
infection: (2) impairment of acquired immunity (via lymphocyte
toxicity) reducing immune elimination; and (3) promotion
of inflammation (cytokine expression by macrophages). Cdt’s
ability to mount a three-pronged attack against host defenses
is facilitated by its unique ability to utilize cholesterol, a
ubiquitous moiety to bind to plasma membranes and to target
cell homeostasis and function through a signaling pathway
common to all cells. It is important to point out that lipid
phosphatase activity has only been demonstrated for CdtB
from A. actinomycetemcomitans. However, based upon sequence
homology, we believe that CdtB from H. ducreyi would exhibit
similar activity. Moreover, since all CdtB’s analyzed to date
exhibit relatively poor DNase activity, it is reasonable to expect
that toxin produced by other bacteria will act through a similar
mode of action. Thus, we anticipate that future studies will
demonstrate that CdtB’s from other Cdt producing pathogens
will exhibit robust PIP3 phosphatase activity similar to that of A.
actinomycetemomitans CdtB.
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